Drug approvals

|

13

Diabetes Drug, Farxiga Shows Promise in Patients With Heart Failure

AstraZeneca announced this week positive results from a landmark trial which showed that its diabetes drug, Farxiga reduced cardiovascular instances, …

| | |

Glenmark to Sell Combination Therapy for Adults With Type 2 Diabetes in India

Glenmark Pharmaceuticals Ltd. announced it has received regulatory approval to market a combination of a novel drug, Remogliflozinc, and Metformin …

New Drug for Diabetes Related Vision Loss Approved in Australia

Patients in Australia with diabetes-induced eye disease now have a new treatment option. The Australian Therapeutic Goods Administration (TGS) has …

|

First and Only Nasally Administered Glucagon Approved by FDA

The U.S. Food and Drug Administration (FDA) has approved Eli Lilly and Company’s BAQSIMI™ (glucagon) nasal powder 3 mg for the treatment …

|

Astra Zeneca’s Drug Does Not Get FDA Approval for Type 1 Diabetes

AstraZeneca announced yesterday that the U.S. Food and Drug Administration (FDA) did not approve its diabetes treatment, Farxiga, for use as a …

|

Novo Nordisk Seeks U.S. FDA Approval for Oral Type 2 Diabetes Medication

Novo Nordisk today announced the submission of two New Drug Applications (NDAs) to the U.S. Food and Drug Administration (FDA) for oral semaglutide, …

|

Eli Lilly and Company Will Introduce Generic Insulin at Half Price of Humalog

Eli Lilly and Company today announced it will introduce a lower-priced version of Humalog®(insulin lispro injection 100 units/mL) in the U.S. The …

Diabasens® Approved in Canada to Relieve Cutaneous Pain Associated with Diabetic Neuropathy

Innovus Pharmaceuticals, Inc., an emerging commercial-stage pharmaceutical company announced that it received approval from Health Canada to market …

|

FDA Approves Expanded Label for Sanofi’s Soliqua

The U.S. Food and Drug Administration (FDA) has approved the use of Sanofi’s Soliqua 100/33 (insulin glargine and lixisenatide injection) 100 …

Novo Nordisk Seeks EMA and FDA Approval for Fiasp® to be Used for Kids

Novo Nordisk recently submitted label updates to the European Medicines Agency (EMA) and the U.S. Food and Drug Administration (FDA) for …